Centrient initiates patent litigation in India against Dalas Biotech

Read more

Special 301 Report 2019: A Deliberate attempt to weaken India’s Patents Act and to tarnish Indian generic pharmaceutical industry

Read more

J&J hip implants: Drug regulator orders compensation for two more patients

Read more

Lupin in alliance with Natco receives USFDA approval for Bosentan tablets

Read more

MTaI supports DTAB’s proposal for new vertical in CDSCO to check ‘garage manufacturing’

Read more

Merck- FSSAI collaboration starts a Center for Microbiological Analysis Training (C-MAT)

Read more

Research conducted at IIT Mandi shows that zinc supplementation suppresses fat deposition in the liver

Read more

Takeda announces Andrey Potapov as ICMEA Area Head

Read more

Glenmark launches novel, globally-researched anti-diabetes drug Remogliflozin in India

Read more

Cipla receives final approval for generic version of Gilead Sciences’ Letairis

Read more